Olema Rocketed 167%, Triggering A Circuit Breaker, JPMorgan's Bullish Price Target Hike

Stock Track

Nov 18, 2025

Shares of Olema Pharmaceuticals, Inc. rocketed 167% in morning trading, triggering a circuit breaker. This explosive movement comes on the heels of a highly positive analyst update from JPMorgan.

JPMorgan, a leading financial institution, has raised its price target for Olema Oncology to $32 from the previous $29, while maintaining an Overweight rating on the stock. This significant increase in the price target reflects growing confidence in the company's potential and future prospects within the oncology sector.

The dramatic pre-market rally suggests that investors are reacting enthusiastically to JPMorgan's bullish stance. Olema Pharmaceuticals, which focuses on developing innovative therapies for women's cancers, appears to be gaining substantial traction in the market. This surge in investor interest could potentially be attributed to optimism surrounding the company's drug pipeline or recent clinical developments, although specific details were not provided in the available news.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1120055568"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120055568\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120055568?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-18 22:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120055568","market":"hk","top_or_hot":-1,"title":"Olema Rocketed 167%, Triggering A Circuit Breaker, JPMorgan's Bullish Price Target Hike","media":"Stock Track","content":"<html><head></head><body><p>Shares of Olema Pharmaceuticals, Inc. rocketed 167% in morning trading, triggering a circuit breaker. This explosive movement comes on the heels of a highly positive analyst update from JPMorgan.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/356e6fb13e3907a0ee2fd58ee6515ea6\" tg-width=\"386\" tg-height=\"129\"/></p><p>JPMorgan, a leading financial institution, has raised its price target for Olema Oncology to $32 from the previous $29, while maintaining an Overweight rating on the stock. This significant increase in the price target reflects growing confidence in the company&#39;s potential and future prospects within the oncology sector.</p><p>The dramatic pre-market rally suggests that investors are reacting enthusiastically to JPMorgan&#39;s bullish stance. Olema Pharmaceuticals, which focuses on developing innovative therapies for women&#39;s cancers, appears to be gaining substantial traction in the market. This surge in investor interest could potentially be attributed to optimism surrounding the company&#39;s drug pipeline or recent clinical developments, although specific details were not provided in the available news.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Olema Rocketed 167%, Triggering A Circuit Breaker, JPMorgan's Bullish Price Target Hike</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOlema Rocketed 167%, Triggering A Circuit Breaker, JPMorgan's Bullish Price Target Hike\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-18 22:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Shares of Olema Pharmaceuticals, Inc. rocketed 167% in morning trading, triggering a circuit breaker. This explosive movement comes on the heels of a highly positive analyst update from JPMorgan.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/356e6fb13e3907a0ee2fd58ee6515ea6\" tg-width=\"386\" tg-height=\"129\"/></p><p>JPMorgan, a leading financial institution, has raised its price target for Olema Oncology to $32 from the previous $29, while maintaining an Overweight rating on the stock. This significant increase in the price target reflects growing confidence in the company&#39;s potential and future prospects within the oncology sector.</p><p>The dramatic pre-market rally suggests that investors are reacting enthusiastically to JPMorgan&#39;s bullish stance. Olema Pharmaceuticals, which focuses on developing innovative therapies for women&#39;s cancers, appears to be gaining substantial traction in the market. This surge in investor interest could potentially be attributed to optimism surrounding the company&#39;s drug pipeline or recent clinical developments, although specific details were not provided in the available news.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OLMA","symbol_name":"Olema Pharmaceuticals, Inc.","start_time":0,"source_url":"","article_id":"1120055568","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120055568","pubTimestamp":1763476606,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Olema Pharmaceuticals, Inc. (OLMA) are experiencing a remarkable surge in pre-market trading on Tuesday, soaring by an astounding 208.80%. This explosive movement comes on the heels of a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OLMA":"Olema Pharmaceuticals, Inc."},"translate_title":"Olema飙升167%，触发熔断，摩根大通上调看涨目标价","themeId":"63db4c8844cbc8a09577788eba75f618","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OLMA":1},"content_text":"Shares of Olema Pharmaceuticals, Inc. rocketed 167% in morning trading, triggering a circuit breaker. This explosive movement comes on the heels of a highly positive analyst update from JPMorgan.JPMorgan, a leading financial institution, has raised its price target for Olema Oncology to $32 from the previous $29, while maintaining an Overweight rating on the stock. This significant increase in the price target reflects growing confidence in the company's potential and future prospects within the oncology sector.The dramatic pre-market rally suggests that investors are reacting enthusiastically to JPMorgan's bullish stance. Olema Pharmaceuticals, which focuses on developing innovative therapies for women's cancers, appears to be gaining substantial traction in the market. This surge in investor interest could potentially be attributed to optimism surrounding the company's drug pipeline or recent clinical developments, although specific details were not provided in the available news.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}